Cue Biopharma Inc
2.43 - 2.62
2.43 - 18.42
Join Discuss about CUE with like-minded investors
right on cue. BULLISH MARKETS
148 Replies 10 👍 14 🔥
By Huw Jones LONDON (Reuters) - Wall Street was headed lower on Wednesday, taking its cue from weaker global shares after U.S. Treasuries were pummelled on the prospect of the Federal Reserve firing on all cylinders next month to quell inflation. Investors also waited for details of the latest package of coordinated sanctions on Russia from the United States and its allies over civilian killings in Ukraine. The dollar hit its highest in almost two years, while expectations of new sanctions raised oil supply concerns to send crude prices higher. S&P500 futures were down 0.9%, with tech-heavy Nasdaq futures off 1.6%, pointing to a second day of selling. The CBOE Volatility index, widely dubbed Wall Street's fear index, rose to 23.25 points, up 10.5%. The MSCI All-Country stock index shed 0.5% as shares fell in Asia and Europe, after Fed Governor Lael Brainard said overnight she expected a combination of interest rate rises and a rapid balance sheet runoff to take U.S. monetary policy to a "more neutral position" later this year. Randy Kroszner, a former Fed Governor and now an economics professor at the University of Chicago Booth School of Business, said the Fed was right to act now while longer-term inflation expectations remained anchored. "Given that we've had significant 8% inflation and it's likely to persist for quite some time, longer-term inflation expectations have not yet become unanchored," Kroszner said. "So, they (Fed policymakers) have the opportunity to maintain credibility, but they need to act boldly and that means rapid rate increases, that means a more rapid winding down of the balance sheet than they would have wanted to do." The focus of investors on Wednesday will be on the release of minutes from the Fed's last policy meeting, out at 1800 GMT. "The minutes will be important for two main reasons. First, for clues on the likelihood of a 50 basis point hike, and what the committee would need to see to warrant a faster pace of hikes," analysts at UniCredit said in a note to clients. RECESSION RISK The gap between 2 and 10-year bond yields was at almost 5 basis points. This closely-watched part of the U.S. yield curve, viewed as a good indicator of recession risk, had been inverted for much of the past week. The yield on benchmark 10-year Treasury notes rose to 2.625%, hitting a three-year high after Brainard's remarks. The U.S. 2-year yield rose to its highest level since January 2019 and the 5-year yield to its highest since December 2018. [US/] DOLLAR HITS 2-YEAR HIGH The dollar index hit 99.386 after reaching its highest since late May 2020 in early trade. The euro was slightly firmer at $1.0923. The greenback was also trading firm against the yen at 123.80 yen given the Bank of Japan's conviction and repeated action last week to hold the yield on 10-year Japanese government bonds below 0.25%. Grace Peters, EMEA head of investment strategy at JPMorgan (NYSE:JPM) Private Bank, said 2022 was probably the last year of above-trend economic growth. "We are seeing Fed policy rapidly moving into restrictive territory. But we don't need to ditch equities, it just means we need to be more risk aware. At this point I would buy the dips but move into higher-quality assets," Peters said. "Markets see the curve inversion as the clock ticking down to the next recession. But it can be up to two years until recession hits and over that period stocks generally see a double-digit upside," she said. CRUDE GAINS The rise in bond yields globally has put pressure on gold, which pays no return. Spot gold slightly weaker at $1,923 per ounce. [GOL/] Oil prices recovered from early losses as the threat of new sanctions on Russia raised supply concerns, but there were fears of weaker demand following an increase in U.S. crude stockpiles and Shanghai's extended lockdown. U.S. crude was up 0.9% at $102.75 a barrel. Brent crude gained 0.5% to $107.20 per barrel. [O/R] In Asia, Hong Kong's Hang Seng index lost 1.8% on its return from a holiday, moving away from a one-month high reached on Monday, Chinese blue chips lost 0.3%. Japan's Nikkei shed 1.6%, while the MSCI's broadest index of Asia-Pacific shares outside Japan skidded 1.3%.
54 Replies 8 👍 14 🔥
here comes energy right on cue
143 Replies 12 👍 15 🔥
they definitely have the cash > @bronco said: The article above @dros posted is your sign! Cue the board authorization for stock buyback PR.
142 Replies 15 👍 7 🔥
The article above @dros posted is your sign! Cue the board authorization for stock buyback PR.
140 Replies 6 👍 15 🔥
Indonesian regulator takes cue from Islamic NGOs, bars crypto sales for institutions https://cointelegraph.com/news/indonesian-regulator-takes-cue-from-islamic-ngos-bars-crypto-sales-for-institutions
134 Replies 14 👍 14 🔥
this actually may look to be a winner like NVDA on better chart observation and I feel Elon is dumping off cue. We have a gap fill from 10/25 that we are entering as we speak, same technical as NVDA. Looks like we could drop to $930 level
40 Replies 9 👍 11 🔥
**@Bitboy_Crypto:** Right on cue https://t.co/SiwQIWclQc https://twitter.com/Bitboy_Crypto/status/1469025916265414664
92 Replies 8 👍 6 🔥
nice work > @sperry said: This CUE trade is turning out well. What a clear case of insider trading :)
120 Replies 8 👍 13 🔥
This CUE trade is turning out well. What a clear case of insider trading :)
92 Replies 6 👍 9 🔥
CUE on other hand majority of calls at/near ask
49 Replies 14 👍 8 🔥
The CUE calls from yesterday up ~12%
109 Replies 7 👍 12 🔥
62 Replies 9 👍 9 🔥
oh you talking about CUE
44 Replies 13 👍 13 🔥
Anyone following that CUE flow?
103 Replies 11 👍 7 🔥
“During our more optimistic years, we explored what could go wrong for stocks in our ‘Exploring the Dark Side’ series, but with our now tepid outlook for flat returns through 2022, we take our cue from Monty Python and look on the bright side,” Subramanian wrote, in a recent update, adding that although record equity duration leaves stocks extremely vulnerable to a sharp rise in yields, the corollary is that lower rates could translate into lots of upside. “A rising discount rate is more negative than ever — a 1ppt increase in the cost of equity could drive the S&P 500 to ~3600, but conversely, a 1ppt drop would push the S&P 500 to 6300,” Subramanian said, pointing out that “convexity matters here, as risks are asymmetric.”
121 Replies 12 👍 8 🔥
I will cue up the tumbleweed pics then
142 Replies 15 👍 8 🔥
Wow, right on cue. Quad 4 M&A
137 Replies 11 👍 6 🔥
Right on cue! 🤐
55 Replies 13 👍 15 🔥
here comes GOOG right on cue with the London session
107 Replies 13 👍 13 🔥
right on cue
149 Replies 7 👍 15 🔥
right on cue
82 Replies 11 👍 9 🔥
Right on Cue, it's Broccoli
50 Replies 12 👍 12 🔥
Then, watch the tape for confirmation. Is the volume now fading post exhaustion move? Yes, demand is gone. That's my cue
68 Replies 9 👍 7 🔥
Brexit and the announcement of a new 'mutant' strain of the virus have been enough to upend the markets although the latter is perhaps not quite as 'new' as first thought. Cue collapse of gbp & the indices no doubt helped along with the 5.6% fall in Tesla in the premarket which btw opens at 4.00 am EST (9.00 am London). Wall Street should be interesting given a $900bn rescue package has now been agreed upon. This combination of dramatic news & falling liquidity is a recipe for a roller coaster ride as volatility to go into overdrive so don't expect to stay in too long & keep your stops tight.
54 Replies 12 👍 13 🔥
Ha! Right on cue!
77 Replies 14 👍 12 🔥
lol right on cue, Russian State Media ZeroHedge is calling MI vote a fraud
71 Replies 8 👍 8 🔥
false break so far on cue
44 Replies 11 👍 15 🔥
Today it’s positive. European equities took the cue from a strong Asian session and pushed higher on Monday morning, with the narrative centering on treatment and vaccine news. Donald Trump is said to be mulling fast-tracking AstraZeneca’s vaccine candidate, whilst the FDA issued an emergency use authorisation for using plasma from recovered patients to treat Covid-19. Shares in Astra rose 2 per cent in early trade. Meanwhile, the US and EU have struck a ‘mini’ deal to cut tariffs on a range of items, which marks an important de-escalation of trade tensions that has dogged relations for many months.
132 Replies 12 👍 7 🔥
might be my cue
98 Replies 11 👍 7 🔥
The S&P 500 flirted with 3,400 in the early part of Wednesday’s session but shot 50pts lower after the minutes were released, ending down 0.44 per cent to 3,374.85. The Dow and Nasdaq both tripped up as well. Asian markets fell overnight. European equity indices are taking their cue from this weak handover and dropped over 1 per cent in early trade, before stocks pulled off the lows after China’s ministry of commerce said this morning that US-China trade talks would resume in the coming days. Vix futures are still pointing to increased volatility as we head towards the US election in November.
115 Replies 13 👍 12 🔥
Never mind all that for now though, stocks keep going up. The S&P 500 rose 1.4 per cent to end at 3,380, just six points under its record closing high at 3,386.15, with the record intraday peak at 3,393.52. Asian stocks broadly followed through, with shares in Tokyo up almost 2 per cent. European stocks failed to take the cue and were a little soft on the open, with the FTSE 100 the laggard at -1 per cent, though 22.3pts are due to BP, Shell, Diageo, AstraZeneca, GSK and Legal & General among others going ex-dividend.
92 Replies 15 👍 10 🔥
Right on cue with vaccine headlines. None of the articles see approval before next spring.
124 Replies 10 👍 11 🔥
no but that flow was my cue
44 Replies 10 👍 9 🔥
The S&P 500 rallied 0.5 per cent to move to the 61.8 per cent retracement, whilst the Nasdaq Composite set a new record high. The Dow finished a little lower. Shares in Asia took the cue to rally, whilst European bourses have opened with strength on Thursday morning. Lots of noise around but equity markets are not showing any real trend - major indices are still sitting around the middle of the June ranges.
125 Replies 15 👍 10 🔥
Today the major bourses have taken their cue from Wall Street and opened higher. Asian markets rose. The FTSE 100 rose more than 2 per cent to back above 6,200 and test the 100-day line resistance, while European counterparts rose by similar amounts. Ashtead Group rose c15 per cent in early trade after it maintained its dividend despite a halving in profits. The infrastructure stimulus touted by the White House would be a massive boost for the construction equipment company
79 Replies 6 👍 14 🔥
Yesterday, I noted that policymakers would be forced to chuck even more money at pandemic relief as second waves of cases and a painful and incomplete economic recovery bit. Right on cue, the Federal Reserve announced it would start buying individual corporate bonds, building on the existing purchases of ETFs. The Fed ‘will purchase corporate bonds to create a corporate bond portfolio that is based on a broad, diversified market index of U.S. corporate bonds’, the central bank said.
122 Replies 13 👍 14 🔥
thats my cue
139 Replies 9 👍 8 🔥
my cue to stop trading when my trusty demo account is broken before news
78 Replies 10 👍 9 🔥
European bourses this morning took the cue from Wall Street and marched higher in early trade. The FTSE 100 added 3 per cent to make a stab at the key 5800-5820 resistance area. If this goes then we could see a run through to 6200. The Euro Stoxx 50 pushed through to 2,900. We’ve got risk on with Healthcare and Telecoms the laggards, but still higher, whilst Travel & Leisure, Banks and Autos led the way higher.
63 Replies 11 👍 15 🔥
Next Dividend Date
Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the patient's body to transform the treatment of cancer, infectious diseases and autoimmune diseases. The company's proprietary platform, Immuno-STAT ™(Selective Targeting and Alteration of T cells) is designed to harness the body's intrinsic immune system without the need for ex vivo manipulation.
CEO: Daniel Passeri
HQ: 21 Erie St Cambridge, 02139-4260 Massachusetts